Crosstalk between Dopamine D2 receptors and cannabinoid CB1 receptors regulates CNR1 promoter activity via ERK1/2 signaling
Open Access
- 17 August 2013
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 127 (2) , 163-176
Abstract
Previously, we found that chronic methamphetamine treatment altered cannabinoid type 1 receptor (CB1R)‐dependent cAMP/PKA/dopamine and cAMP‐regulated phosphoprotein of Mr 32 000 (DARPP‐32)/T34/PP2B signaling and decreased levels of CB1R protein and mRNA in the nucleus accumbens. These findings suggested the existence of signaling interplay between mesolimbic dopamine and CB1R. In this study, we further investigate interactions between CB1R and dopamine D2 receptor (D2R) signaling. Activation of either CB1R or D2R increased extracellular signal‐regulated kinases 1 and 2 (ERK1/2) phosphorylation, while co‐stimulation of CB1R and D2R evoked an additive effect on the phospho‐ERK1/2 signal. This effect was mediated through a pertussis toxin‐sensitive Gαi/o pathway in primary striatal cells. Furthermore, the mRNA level of CB1R was increased via dopamine D2 receptor short form (D2SR) by treatment with D2R agonist quinpirole in D2SR/C6 glioma cells. This effect could be suppressed by co‐treatment with the ERK1/2 inhibitor U0126. To test if D2SR could transcriptionally regulate CB1R, the 5′‐untranslated region (5′‐UTR) of the cannabinoid receptor 1 (CNR1) gene was sequenced from rat brain. Results showed that the CNR1 gene includes two exons, which contain 375 bp of 5′‐UTR and are separated by a 17‐kb intron. A luciferase reporter assay showed that the maximal D2SR‐responsive promoter activity is located in the −1 to −222 region of CNR1 promoter. Overall, we demonstrate previously unidentified crosstalk between D2R and CB1R via ERK1/2 signaling that enhances the expression of CB1R by modulating its promoter activity. image Cannabinoid CB1R and dopamine D2R cross‐talk at ERK1/2 signal. Activation of D2SR increases the CB1R transcription, which is ERK1/2 dependent and enhances CB1R promoter activity that requires up‐stream −1 to −222 region. The results implicate pre‐synaptic D2SR could functionally regulate the retrograde cannabinoid signal in the striatum.Keywords
Funding Information
- Chang-Gung Memorial Hospital (CMRPD180521)
- National Science Council (NSC97-2321-B-182-018-MY3)
- National Health Research Institutes (NHRI-EX102-10224NC, NHRI-102A1-PDCO-1312141)
- China Medical University Hospital (DMR-96-078, DMR-102-030)
This publication has 58 references indexed in Scilit:
- Dopamine D2 Receptor-Mediated AKT/PKB Signalling: Initiation by the D2S Receptor and Role in Quinpirole-Induced Behavioural ActivationASN Neuro, 2012
- The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic ImplicationsPharmacological Reviews, 2011
- Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal CortexJournal of Neuroscience, 2010
- Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor HeterodimersThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Striatal Dopamine D2/D3Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to ImpulsivityThe Journal of Neuroscience, 2009
- D2Dopamine Receptor Activation Facilitates Endocannabinoid-Mediated Long-Term Synaptic Depression of GABAergic Synaptic Transmission in Midbrain Dopamine Neurons via cAMP-Protein Kinase A SignalingJournal of Neuroscience, 2008
- Analysis of Promoter Regions Regulating Basal and Interleukin-4-Inducible Expression of the Human CB1 Receptor Gene in T LymphocytesMolecular Pharmacology, 2008
- Regulation of psychostimulant‐induced signaling and gene expression in the striatumJournal of Neurochemistry, 2008
- ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentiallyJournal of Biology, 2006
- Adenosine A2a blockade prevents synergy between μ-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted ratsProceedings of the National Academy of Sciences, 2006